Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Heron Therapeutics (HRTX) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for Heron Therapeutics (HRTX) over the last 15 years, with Dec 2024 value amounting to $3.5 million.

  • Heron Therapeutics' Interest & Investment Income was N/A to $1.1 million in Q4 2016 from the same period last year, while for Dec 2016 it was $445,000, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2024, which is 5.53% up from last year.
  • Heron Therapeutics' Interest & Investment Income amounted to $3.5 million in FY2024, which was up 5.53% from $3.4 million recorded in FY2023.
  • In the past 5 years, Heron Therapeutics' Interest & Investment Income ranged from a high of $3.6 million in FY2020 and a low of $433,000 during FY2021.
  • For the 3-year period, Heron Therapeutics' Interest & Investment Income averaged around $2.9 million, with its median value being $3.4 million (2023).
  • In the last 5 years, Heron Therapeutics' Interest & Investment Income plummeted by 88.08% in 2021 and then spiked by 278.29% in 2022.
  • Over the past 5 years, Heron Therapeutics' Interest & Investment Income (Yearly) stood at $3.6 million in 2020, then crashed by 88.08% to $433,000 in 2021, then spiked by 278.29% to $1.6 million in 2022, then soared by 105.37% to $3.4 million in 2023, then climbed by 5.53% to $3.5 million in 2024.